GMP 细胞库服务市场（按服务类型、细胞类型、细胞库类型、应用和最终用户划分）—2025 年至 2030 年全球预测

GMP细胞库服务市场预计将从2024年的9.9639亿美元成长到2025年的11.1327亿美元，复合年增长率为12.10%，到2030年将达到19.7796亿美元。

主要市场统计数据
基准年2024年	9.9639亿美元
预计2025年	1,113,270,000美元
预测年份 2030	19.7796亿美元
复合年增长率（%）	12.10%

推出以严格的品管、先进的生物加工突破和全球供应链整合为驱动力的精准细胞库解决方案

GMP细胞库领域不断发展，已成为现代生物製药开发的重要支柱，推动创新并确保关键生技药品的可重复性。随着企业努力提高细胞株稳定性并简化生产流程，强大的品管措施和先进的生物製程平台已成为成功细胞库策略不可或缺的要素。精准工程与严谨监管的结合，提高了人们对製程一致性、产品安全性和可追溯性的期望。

新技术与监管变革如何重新定义全球GMP细胞库实务的标准

近年来，技术创新和监管变革的交汇再形成了GMP细胞库的格局。如今，自动化高通量平台能够以极少的人工干预处理复杂的样品製备和活力评估，从而提高可重复性并降低污染风险。同时，由人工智慧演算法驱动的数位过程控制系统能够实现预测性维护和自适应回馈迴路，从而维持最佳培养条件。

评估2025年美国关税对品质主导的细胞库和全球生物製药供应安全的深远影响

2025年美国新关税的实施，为依赖跨国采购关键试剂和设备的细胞库企业带来了复杂的策略考量。专用培养基成分、冷冻保护剂和一次性耗材等原料的进口关税将上调，迫使企业重新评估筹资策略和供应链配置。

揭示细胞库市场在细胞类型、产品线、应用、最终用户、供应来源、规模、储存、加工方法和分销管道方面的详细细分

细胞库市场的复杂性源自于细胞类型的多样性，每种细胞类型都有其独特的特性和需求。 Sf21、Sf9 和 Tn5 等昆虫细胞株擅长高产蛋白表达，但需要独特的培养条件和病毒载体系统。 CHO 和 HEK293 细胞等哺乳动物宿主为治疗性糖蛋白提供了无与伦比的兼容性，而 NS0 和融合瘤系则支持单株抗体的生产。微生物平台同样涵盖细菌系统，例如芽孢桿菌和大肠桿菌菌株，以及酵母宿主，例如毕赤酵母和酿酒酵母，每个平台都兼顾了快速生长和转译后修饰能力。

揭示影响美洲、欧洲、中东和非洲以及亚太市场细胞银行创新和采用模式的区域动态

地理动态对GMP细胞库解决方案的开发和实施有重大影响。北美和拉丁美洲凭藉其成熟的法律规范和专业的人才储备，已经建立了生物製药中心网络。在拉丁美洲，成本结构和物流效率正在推动对区域生产中心的策略性投资，以补充该地区的临床试验需求，尤其是在生物相似药和疫苗方面。

介绍推动全球生物製造领域技术创新、卓越营运和策略合作的领先细胞库服务供应商

GMP细胞库领域的领先服务供应商以其对技术领先地位、营运扩充性和协作敏捷性的追求而闻名。多家全球性公司已建立多设施布局，整合自动化低温保存设备和先进的分析平台，支援高容量样本处理。这些机构拥有丰富的试剂和耗材库存，以确保快速的周转时间，并最大限度地减少供应链中断。

产业领导者在推动GMP细胞库营运合规性、可扩展性和创新方面的策略挑战和主动倡议

产业领导者若希望利用不断发展的GMP细胞库环境，应优先考虑对自动化和数位监控工具进行策略性投资。透过整合即时分析和流程控制演算法，企业可以显着降低差异性并加快产品发布週期。同时，透过区域采购伙伴关係和倡议实现供应路线多元化，可以增强企业应对关税引发的成本压力和运输瓶颈的能力。

透明而严谨的混合调查方法为全面分析 GMP 细胞库市场趋势和竞争格局奠定了基础

该分析基于严格的混合方法框架，整合了基础研究、二手资料审查和专家检验。初始阶段包括与各相关人员的深入访谈，包括细胞库管理层、品质保证专家、监管顾问和设备供应商。这些对话提供了关于营运痛点、技术采用障碍和策略重点的定性见解。

综合洞察，掌握未来机会，应对不断发展的 GMP 细胞库生态系统中的挑战

GMP细胞库产业正面临前所未有的技术进步、监管调整和地缘政治影响，相关人员必须整合多方面的洞见，制定更具韧性的发展路径。新的模式在于协调自动化流程管理、敏捷的供应链和协作创新生态系统，以满足对生物治疗药物和细胞产品日益增长的需求。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

• 扩展 GMP 细胞库的自动化程度，以提高可重复性和通量
• 实施封闭的生物工艺，最大限度地降低细胞库生产过程中的污染风险
• 整合即时分析和数位监控增强了 GMP 细胞库的品质保证
• 同种异体细胞疗法的引入正在推动可扩展 GMP 细胞库基础设施和容量的需求
• 标准化冷冻保存通讯协定以提高治疗细胞库的长期稳定性和活力
• CDMO与生物技术公司之间的策略伙伴关係扩大了区域GMP细胞库网路的影响力
• 监管协调努力将简化细胞库GMP级细胞治疗产品的国际核准

第六章 市场洞察

• 波特五力分析
• PESTEL分析

第七章 2025年美国关税的累积影响

8. GMP细胞库服务市场（依服务类型）

• 细胞银行和储存
• 细胞株开发与表征
• 监管支持和文件
• 测试和品管
  • 外来性病原体检测
  • 基因稳定性测试
  • 背景调查
  • 纯度测试
  • 无菌测试

9. GMP细胞库服务市场（依细胞类型）

• 昆虫细胞
• 哺乳动物细胞
  • CHO细胞
  • HEK293细胞
  • NS0/Sp2细胞
  • Vero细胞
• 微生物细胞
  • 细菌细胞
  • 酵母菌细胞
• 干细胞
  • 胚胎干细胞
  • 诱导性多功能干细胞（iPSC）
  • 间质干细胞（MSCs）

10. GMP细胞库服务市场（依细胞库类型）

• 停产细胞库（EOPCB）
• 主细胞库（MCB）
• 研究细胞库（RCB）
• 工作细胞库（WCB）

第 11 章 GMP 细胞库服务市场（按应用）

• 生物製药製造
  • 基因和细胞治疗
  • 单株抗体
  • 重组蛋白
  • 疫苗
• 细胞疗法
• 药物研发
• 组织工程与再生医学

第 12 章 GMP 细胞库服务市场（按最终用户）

• 学术研究机构
• 合约研究与製造组织
• 医院和诊所
• 製药和生物技术公司

13.美洲GMP细胞库服务市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 阿根廷

14.欧洲、中东和非洲GMP细胞库服务市场

• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 阿拉伯聯合大公国
• 沙乌地阿拉伯
• 南非
• 丹麦
• 荷兰
• 卡达
• 芬兰
• 瑞典
• 奈及利亚
• 埃及
• 土耳其
• 以色列
• 挪威
• 波兰
• 瑞士

15.亚太地区GMP细胞库服务市场

• 中国
• 印度
• 日本
• 澳洲
• 韩国
• 印尼
• 泰国
• 菲律宾
• 马来西亚
• 新加坡
• 越南
• 台湾

第十六章竞争格局

• 2024年市场占有率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • 53Biologics
  • Austrianova
  • Cell Culture Company, LLC
  • Charles River Laboratories
  • Clean Cells
  • Eurofins Scientific Limited
  • ExcellGene SA
  • Goodwin Biotechnology Inc.
  • Kaneka Eurogentec SA
  • Lonza Group Ltd.
  • Merck KGaA
  • NAOBIOS
  • PackGene Biotech lnc.
  • ProBio Biotech Corporation
  • RoslinCT
  • SGS Group
  • SK pharmteco Inc.
  • Takara Bio Inc.
  • Texcell SA
  • uBriGene Biosciences International Co.
  • ViruSure GmbH
  • Wacker Chemie AG
  • WuXi Biologics
  • OmniaBio
  • eXmoor pharma concepts ltd

第十七章 研究人工智慧

第十八章 研究统计

第十九章 研究联络人

第二十章 研究报导

第21章 附录

The GMP Cell Banking Services Market was valued at USD 996.39 million in 2024 and is projected to grow to USD 1,113.27 million in 2025, with a CAGR of 12.10%, reaching USD 1,977.96 million by 2030.

KEY MARKET STATISTICS
Base Year [2024]	USD 996.39 million
Estimated Year [2025]	USD 1,113.27 million
Forecast Year [2030]	USD 1,977.96 million
CAGR (%)	12.10%

Heralding the Dawn of Precision Cell Banking Solutions Fueled by Rigorous Quality Controls, Advanced Bioprocessing Breakthroughs, and Global Supply Chain Integration

The evolving field of GMP cell banking has become an indispensable pillar of modern biopharmaceutical development, driving innovation and ensuring the reproducibility of critical biologics. As organizations endeavor to enhance their cell line stability and streamline production workflows, robust quality control measures and advanced bioprocessing platforms have emerged as nonnegotiable components of any successful cell banking strategy. The convergence of precision engineering and regulatory rigor has elevated expectations for process consistency, product safety, and traceability.

Consequently, industry leaders are embracing automated systems that integrate real-time monitoring with stringent data capture protocols, enabling tighter control over every stage of the cell banking journey. Furthermore, breakthroughs in cryopreservation and lyophilization techniques are extending cell viability windows and reducing logistical risks across global supply chains. Collectively, these advances are reshaping traditional paradigms, allowing manufacturers to respond more nimbly to evolving therapeutic demands.

Looking ahead, the interplay between next-generation analytics, digital twins, and predictive modeling promises to further transform how cell banks are designed, scaled, and qualified. By anticipating shifts in raw material availability, regulatory guidance, and market dynamics, stakeholders can cultivate resilient operations that align with both current obligations and future aspirations. This introduction sets the stage for a comprehensive exploration of the forces driving the next chapter in GMP cell banking excellence.

How Emerging Technologies and Regulatory Evolution Are Redefining Standards for GMP Cell Banking Practices Worldwide

In recent years, the GMP cell banking landscape has been reshaped by a confluence of technological innovations and regulatory transformations. Automated high-throughput platforms now handle complex sample preparation and viability assessments with minimal human intervention, driving reproducibility while mitigating contamination risks. Concurrently, digital process control systems, empowered by artificial intelligence algorithms, enable predictive maintenance and adaptive feedback loops that sustain optimal culture conditions.

At the same time, regulatory authorities across major markets are harmonizing guidelines to reflect contemporary manufacturing practices. Updated frameworks emphasize risk-based approaches, process validation by design, and lifecycle management, placing a premium on comprehensive data integrity and real-time oversight. Manufacturers are responding by integrating quality management systems that seamlessly link laboratory information management with electronic batch records.

Moreover, strategic partnerships between instrument suppliers, cell therapy developers, and contract manufacturing organizations are accelerating the translation of research-stage cell lines into clinically compliant master and working banks. These collaborations foster knowledge exchange, expedite technology transfer, and support capacity expansion. As a result, the industry is witnessing a holistic shift toward end-to-end digitization, decentralized production footprints, and collaborative innovation networks that collectively elevate the standard of GMP cell banking.

Assessing the Far-Reaching Consequences of United States Tariffs in 2025 on Quality-Driven Cell Banking Operations and Global Biopharma Supply Security

The implementation of newly instituted tariffs by the United States in 2025 has introduced a complex layer of strategic considerations for cell banking operations that depend on cross-border sourcing of critical reagents and equipment. Raw materials such as specialized media components, cryoprotectants, and single-use consumables have been subject to elevated import duties, compelling organizations to reassess their procurement strategies and supply chain configurations.

Consequently, several manufacturers have turned to nearshoring initiatives and regional sourcing alliances to mitigate cost surges and maintain uninterrupted production cycles. These efforts are further supported by collaborative agreements with domestic suppliers who can offer localized warehousing, reduced lead times, and co-investment in quality certification processes. Nevertheless, some high-precision instrumentation and niche bioreagents remain reliant on established international suppliers, sustaining a degree of exposure to tariff-driven price inflation.

In response, innovative finance models such as dynamic pricing contracts and duty-deferred warehousing have emerged to buffer the impact on end users. Companies are also revisiting their inventory management protocols, balancing just-in-time delivery with strategic stockpiling for mission-critical components. As a result, the interplay between cost containment and supply chain resilience has become a defining theme for GMP cell banking stakeholders navigating the post-tariff environment.

Illuminating Detailed Cell Banking Market Segmentation Across Cell Types, Product Lines, Applications, End Users, Sources, Scale, Storage, Process Methodologies, and Distribution Channels

The cell banking market's complexity is rooted in a diverse array of cell types, each with distinct characteristics and demands. Insect cell lines, including Sf21, Sf9, and Tn5, excel in high-yield protein expression but require tailored culture conditions and viral vector systems. Mammalian hosts such as CHO and HEK293 cells offer unmatched compatibility for therapeutic glycoproteins, while NS0 and hybridoma lines underpin monoclonal antibody production. Microbial platforms likewise span bacterial systems like Bacillus species and E. coli strains, as well as yeast hosts such as Pichia pastoris and Saccharomyces cerevisiae, each balancing rapid growth with post-translational modification capabilities.

Beyond cell type, the differentiation between primary and working cell banks shapes storage protocols, quality testing cycles, and regulatory submissions. Primary repositories represent the definitive genetic baseline, whereas working banks enable scalable downstream processing. Applications range from clinical batch production to foundational research and development, demanding distinct validation and documentation pathways.

End-user segmentation further refines market dynamics. Academic research organizations, including government institutes and universities, drive fundamental discovery and early-stage validation, while biopharmaceutical companies prioritize commercial production alignment and regulatory compliance. Contract research organizations serve as pivotal partners for outsourcing specialized services. Sources of cell material, whether allogeneic from sibling or unrelated donors or patient-specific autologous origins, dictate donor screening workflows and chain-of-custody requirements.

Operational scale bifurcates into clinical-use banks for Phase I, II, and III studies and commercial-use banks that support full market launch. Storage technologies range from cryopreservation, which secures long-term viability under ultra-low temperatures, to lyophilization techniques that enable room-temperature stability under select conditions. Process modalities vary between fully automated systems designed for high throughput and manual workflows that offer flexibility for niche applications. Finally, distribution relies on a balance between direct sales channels, which afford end-to-end oversight, and specialized distributors capable of navigating regional regulatory frameworks and logistical complexities.

Unveiling Regional Dynamics Shaping Cell Banking Innovation and Adoption Patterns Across the Americas, Europe Middle East Africa and Asia Pacific Markets

Geographic dynamics exert a profound influence on the development and adoption of GMP cell banking solutions. Within the Americas, a well-established network of biopharmaceutical hubs in North America benefits from mature regulatory frameworks and deep pools of specialized talent. Cost structures and logistical efficiencies in Latin America are attracting strategic investments in regional production sites, particularly for biosimilar and vaccine initiatives, which complement local clinical trial demands.

Transitioning to Europe, the Middle East, and Africa, the regulatory landscape presents both harmonization opportunities and jurisdictional nuances. European Union directives promote centralized oversight and mutual recognition of supplier certifications, while emerging markets in the Middle East and Africa are prioritizing capacity building and technology transfer programs. These regions collectively leverage cross-border trade agreements to facilitate equipment importation and collaborative research partnerships.

Asia-Pacific is experiencing rapid growth driven by government-sponsored biotechnology clusters in China, India, Japan, and South Korea. Incentive programs and public-private partnerships are accelerating the construction of state-of-the-art cell banking facilities. Cost advantages and expanding local manufacturing capabilities are capturing the interest of multinational firms seeking to diversify production footprints. As a result, Asia-Pacific has become a focal point for strategic alliances, joint ventures, and commercial expansions that will shape the next wave of global cell banking innovation.

Profiling Leading Cell Banking Service Providers Driving Technological Innovation, Operational Excellence, and Strategic Collaborations in the Global Biomanufacturing Landscape

Leading service providers in the GMP cell banking arena are distinguished by their commitment to technological leadership, operational scalability, and collaborative agility. Several global entities have established multi-facility footprints, integrating automated cryostorage units with advanced analytics platforms to support high-volume sample throughput. These organizations maintain extensive reagent and consumable inventories to guarantee rapid turnaround times and minimize supply chain disruptions.

Strategic partnerships between cell line developers and contract manufacturing organizations have unlocked co-development pathways for proprietary expression systems. Meanwhile, technology licensors are forging alliances with instrumentation companies to seamlessly integrate closed-system bioreactors and in-line monitoring solutions into cell banking workflows. Cross-industry collaborations are also facilitating the standardization of assay protocols and quality benchmarks, which accelerates regulatory approvals and fosters mutual recognition of master cell bank certifications.

Furthermore, a select group of innovative providers is exploring decentralized cell banking models that leverage distributed network architectures, enabling clients to deploy satellite cryostorage units under centralized data governance frameworks. These flexible offerings cater to diverse scales of operation, from early-stage research projects to large-scale commercial programs. By combining end-to-end process validation with real-time digital dashboards, these market leaders are defining new service benchmarks for reliability, transparency, and customer responsiveness.

Strategic Imperatives and Proactive Initiatives for Industry Leaders to Advance Compliance, Scalability, and Innovation in GMP Cell Banking Operations

Industry leaders aiming to capitalize on the evolving GMP cell banking environment should prioritize strategic investments in automation and digital monitoring tools. By embedding real-time analytics and process control algorithms, organizations can significantly reduce variability and accelerate product release cycles. Concurrently, diversifying supply routes through regional sourcing partnerships and nearshoring initiatives will bolster resilience against tariff-induced cost pressures and transportation bottlenecks.

In parallel, proactive engagement with regulatory bodies is essential to anticipate guideline updates and to influence emerging standards. Establishing joint working groups and participating in industry consortia can provide early visibility into forthcoming policy shifts, enabling organizations to adapt documentation, validation, and risk management programs ahead of enforcement deadlines.

From an operational perspective, embracing a hybrid approach that combines centralized data repositories with decentralized cryostorage nodes enhances both oversight and flexibility. Coupling this with robust quality management systems ensures that donor screening, cell characterization, and chain-of-custody protocols remain consistent across multiple geographies. Finally, fostering collaborative innovation via academia-industry partnerships and joint R&D ventures will unlock novel cell line platforms and process intensification strategies, propelling the next generation of therapeutic breakthroughs.

Transparent and Rigorous Mixed-Method Research Methodology Underpinning Comprehensive Analysis of GMP Cell Banking Market Trends and Competitive Landscapes

This analysis is founded upon a rigorous mixed-methodology framework that integrates primary research, secondary data review, and expert validation. In the initial phase, in-depth interviews were conducted with a spectrum of stakeholders, including cell bank managers, quality assurance specialists, regulatory advisors, and equipment suppliers. These conversations yielded qualitative insights into operational pain points, technology adoption hurdles, and strategic priorities.

Simultaneously, an exhaustive secondary research effort aggregated technical white papers, regulatory guidance documents, company filings, and peer-reviewed studies. These sources were systematically evaluated to map historical trends, benchmark best practices, and identify emerging innovation pockets. Quantitative data sets were subjected to thorough cross-validation procedures, ensuring consistency and reliability across regional and segmental analyses.

Subsequent expert panels convened subject matter authorities to critique preliminary findings, refine segmentation frameworks, and stress-test hypothetical scenarios related to tariff fluctuations, regulatory reforms, and technology disruptions. The resulting triangulated insights reflect a consensus-driven perspective that balances forward-looking projections with empirical evidence. Throughout the research process, stringent data integrity protocols and confidentiality safeguards were maintained to uphold analytical transparency and stakeholder trust.

Integrating Insights to Navigate Future Opportunities and Mitigate Challenges in the Evolving GMP Cell Banking Ecosystem

As the GMP cell banking sector confronts an era of unprecedented technological advances, regulatory reshaping, and geopolitical influences, stakeholders must integrate multifaceted insights to chart a resilient course forward. The emergent paradigm centers on harmonizing automated process controls, agile supply chains, and collaborative innovation ecosystems to meet rising demands for biologic therapies and cell-based products.

Looking forward, success will hinge upon the ability to adapt to shifting tariff landscapes, harness data-driven decision frameworks, and establish strategic partnerships that transcend traditional industry boundaries. Organizations that proactively refine their quality management architectures and engage in policy dialogues will be best positioned to navigate upcoming guideline changes and market entry requirements.

Ultimately, the convergence of digital biomanufacturing tools, precision analytics, and decentralized cell storage networks offers a compelling blueprint for sustainable growth. By embracing this integrated approach, stakeholders can unlock new avenues of differentiation, accelerate time-to-clinic, and ensure the consistent delivery of safe, high-quality cell banks that underpin the next generation of therapeutic innovations.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Sizing & Forecasting

5. Market Dynamics

• 5.1. Expansion of automation technologies in GMP cell banking to enhance reproducibility and throughput
• 5.2. Implementation of closed-system bioprocessing to minimize contamination risk during cell bank production
• 5.3. Integration of real-time analytics and digital monitoring for enhanced GMP cell banking quality assurance
• 5.4. Adoption of allogeneic cell therapies driving demand for scalable GMP cell banking infrastructure and capacity
• 5.5. Standardization of cryopreservation protocols to improve long-term stability and viability of therapeutic cell banks
• 5.6. Strategic partnerships between CDMOs and biotech companies expanding regional GMP cell banking network presence
• 5.7. Regulatory harmonization efforts to streamline international approval of GMP-grade cell therapy products for cell banks

6. Market Insights

• 6.1. Porter's Five Forces Analysis
• 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. GMP Cell Banking Services Market, by Service Type

• 8.1. Introduction
• 8.2. Cell Banking & Storage
• 8.3. Cell Line Development & Characterization
• 8.4. Regulatory Support & Documentation
• 8.5. Testing & Quality Control
  • 8.5.1. Adventitious Agent Testing
  • 8.5.2. Genetic Stability Testing
  • 8.5.3. Identity Testing
  • 8.5.4. Purity Testing
  • 8.5.5. Sterility Testing

9. GMP Cell Banking Services Market, by Cell Type

• 9.1. Introduction
• 9.2. Insect Cells
• 9.3. Mammalian Cells
  • 9.3.1. CHO Cells
  • 9.3.2. HEK293 Cells
  • 9.3.3. NS0/Sp2 Cells
  • 9.3.4. Vero Cells
• 9.4. Microbial Cells
  • 9.4.1. Bacterial Cells
  • 9.4.2. Yeast Cells
• 9.5. Stem Cells
  • 9.5.1. Embryonic Stem Cells
  • 9.5.2. Induced Pluripotent Stem Cells (iPSCs)
  • 9.5.3. Mesenchymal Stem Cells (MSCs)

10. GMP Cell Banking Services Market, by Cell Bank Type

• 10.1. Introduction
• 10.2. End-of-Production Cell Bank (EOPCB)
• 10.3. Master Cell Bank (MCB)
• 10.4. Research Cell Bank (RCB)
• 10.5. Working Cell Bank (WCB)

11. GMP Cell Banking Services Market, by Application

• 11.1. Introduction
• 11.2. Biopharmaceutical Production
  • 11.2.1. Gene & Cell Therapies
  • 11.2.2. Monoclonal Antibodies
  • 11.2.3. Recombinant Proteins
  • 11.2.4. Vaccines
• 11.3. Cell Therapy
• 11.4. Drug Discovery & Development
• 11.5. Tissue Engineering & Regenerative Medicine

12. GMP Cell Banking Services Market, by End User

• 12.1. Introduction
• 12.2. Academic & Research Institutes
• 12.3. Contract Research & Manufacturing Organizations
• 12.4. Hospitals & Clinics
• 12.5. Pharmaceutical & Biotechnology Companies

13. Americas GMP Cell Banking Services Market

• 13.1. Introduction
• 13.2. United States
• 13.3. Canada
• 13.4. Mexico
• 13.5. Brazil
• 13.6. Argentina

14. Europe, Middle East & Africa GMP Cell Banking Services Market

• 14.1. Introduction
• 14.2. United Kingdom
• 14.3. Germany
• 14.4. France
• 14.5. Russia
• 14.6. Italy
• 14.7. Spain
• 14.8. United Arab Emirates
• 14.9. Saudi Arabia
• 14.10. South Africa
• 14.11. Denmark
• 14.12. Netherlands
• 14.13. Qatar
• 14.14. Finland
• 14.15. Sweden
• 14.16. Nigeria
• 14.17. Egypt
• 14.18. Turkey
• 14.19. Israel
• 14.20. Norway
• 14.21. Poland
• 14.22. Switzerland

15. Asia-Pacific GMP Cell Banking Services Market

• 15.1. Introduction
• 15.2. China
• 15.3. India
• 15.4. Japan
• 15.5. Australia
• 15.6. South Korea
• 15.7. Indonesia
• 15.8. Thailand
• 15.9. Philippines
• 15.10. Malaysia
• 15.11. Singapore
• 15.12. Vietnam
• 15.13. Taiwan

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. 53Biologics
  • 16.3.2. Austrianova
  • 16.3.3. Cell Culture Company, LLC
  • 16.3.4. Charles River Laboratories
  • 16.3.5. Clean Cells
  • 16.3.6. Eurofins Scientific Limited
  • 16.3.7. ExcellGene SA
  • 16.3.8. Goodwin Biotechnology Inc.
  • 16.3.9. Kaneka Eurogentec S.A.
  • 16.3.10. Lonza Group Ltd.
  • 16.3.11. Merck KGaA
  • 16.3.12. NAOBIOS
  • 16.3.13. PackGene Biotech lnc.
  • 16.3.14. ProBio Biotech Corporation
  • 16.3.15. RoslinCT
  • 16.3.16. SGS Group
  • 16.3.17. SK pharmteco Inc.
  • 16.3.18. Takara Bio Inc.
  • 16.3.19. Texcell SA
  • 16.3.20. uBriGene Biosciences International Co.
  • 16.3.21. ViruSure GmbH
  • 16.3.22. Wacker Chemie AG
  • 16.3.23. WuXi Biologics
  • 16.3.24. OmniaBio
  • 16.3.25. eXmoor pharma concepts ltd

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

• FIGURE 1. GMP CELL BANKING SERVICES MARKET RESEARCH PROCESS
• FIGURE 2. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 3. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 4. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
• FIGURE 6. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
• FIGURE 8. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2024 VS 2030 (%)
• FIGURE 10. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 12. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 14. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 16. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 18. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 21. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 22. ASIA-PACIFIC GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 23. GMP CELL BANKING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 24. GMP CELL BANKING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
• FIGURE 25. GMP CELL BANKING SERVICES MARKET: RESEARCHAI
• FIGURE 26. GMP CELL BANKING SERVICES MARKET: RESEARCHSTATISTICS
• FIGURE 27. GMP CELL BANKING SERVICES MARKET: RESEARCHCONTACTS
• FIGURE 28. GMP CELL BANKING SERVICES MARKET: RESEARCHARTICLES

LIST OF TABLES

• TABLE 1. GMP CELL BANKING SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, 2025-2030 (USD MILLION)
• TABLE 5. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 7. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 9. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
• TABLE 11. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANKING & STORAGE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANKING & STORAGE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 13. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL LINE DEVELOPMENT & CHARACTERIZATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL LINE DEVELOPMENT & CHARACTERIZATION, BY REGION, 2025-2030 (USD MILLION)
• TABLE 15. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY REGULATORY SUPPORT & DOCUMENTATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY REGULATORY SUPPORT & DOCUMENTATION, BY REGION, 2025-2030 (USD MILLION)
• TABLE 17. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, BY REGION, 2025-2030 (USD MILLION)
• TABLE 19. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY ADVENTITIOUS AGENT TESTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY ADVENTITIOUS AGENT TESTING, BY REGION, 2025-2030 (USD MILLION)
• TABLE 21. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY GENETIC STABILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY GENETIC STABILITY TESTING, BY REGION, 2025-2030 (USD MILLION)
• TABLE 23. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY IDENTITY TESTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY IDENTITY TESTING, BY REGION, 2025-2030 (USD MILLION)
• TABLE 25. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY PURITY TESTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY PURITY TESTING, BY REGION, 2025-2030 (USD MILLION)
• TABLE 27. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY STERILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY STERILITY TESTING, BY REGION, 2025-2030 (USD MILLION)
• TABLE 29. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
• TABLE 31. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
• TABLE 33. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY INSECT CELLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY INSECT CELLS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 35. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 37. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CHO CELLS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 39. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY HEK293 CELLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY HEK293 CELLS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 41. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY NS0/SP2 CELLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY NS0/SP2 CELLS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 43. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY VERO CELLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY VERO CELLS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 45. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
• TABLE 47. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 49. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BACTERIAL CELLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BACTERIAL CELLS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 51. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY YEAST CELLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY YEAST CELLS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 53. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
• TABLE 55. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 57. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 59. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS (IPSCS), BY REGION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS (IPSCS), BY REGION, 2025-2030 (USD MILLION)
• TABLE 61. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS (MSCS), BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MESENCHYMAL STEM CELLS (MSCS), BY REGION, 2025-2030 (USD MILLION)
• TABLE 63. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
• TABLE 65. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
• TABLE 67. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END-OF-PRODUCTION CELL BANK (EOPCB), BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END-OF-PRODUCTION CELL BANK (EOPCB), BY REGION, 2025-2030 (USD MILLION)
• TABLE 69. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MASTER CELL BANK (MCB), BY REGION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MASTER CELL BANK (MCB), BY REGION, 2025-2030 (USD MILLION)
• TABLE 71. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH CELL BANK (RCB), BY REGION, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RESEARCH CELL BANK (RCB), BY REGION, 2025-2030 (USD MILLION)
• TABLE 73. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY WORKING CELL BANK (WCB), BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY WORKING CELL BANK (WCB), BY REGION, 2025-2030 (USD MILLION)
• TABLE 75. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 77. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2025-2030 (USD MILLION)
• TABLE 79. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY GENE & CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY GENE & CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 81. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 83. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 85. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 87. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
• TABLE 89. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
• TABLE 91. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
• TABLE 93. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 95. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 97. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 99. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 101. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 103. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL GMP CELL BANKING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 105. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 106. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
• TABLE 107. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
• TABLE 108. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
• TABLE 109. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 110. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
• TABLE 111. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
• TABLE 112. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
• TABLE 113. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
• TABLE 114. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
• TABLE 115. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
• TABLE 116. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
• TABLE 117. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
• TABLE 118. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
• TABLE 119. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 120. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 121. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
• TABLE 122. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
• TABLE 123. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 124. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 125. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. AMERICAS GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 127. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 128. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
• TABLE 129. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
• TABLE 130. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
• TABLE 131. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 132. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
• TABLE 133. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
• TABLE 134. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
• TABLE 135. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
• TABLE 136. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
• TABLE 137. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
• TABLE 138. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
• TABLE 139. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
• TABLE 140. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
• TABLE 141. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 142. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 143. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
• TABLE 144. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
• TABLE 145. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 146. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 147. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
• TABLE 148. UNITED STATES GMP CELL BANKING SERVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
• TABLE 149. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 150. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
• TABLE 151. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
• TABLE 152. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
• TABLE 153. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 154. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
• TABLE 155. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
• TABLE 156. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
• TABLE 157. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
• TABLE 158. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
• TABLE 159. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
• TABLE 160. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
• TABLE 161. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
• TABLE 162. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
• TABLE 163. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 164. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 165. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
• TABLE 166. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
• TABLE 167. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 168. CANADA GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 169. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 170. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
• TABLE 171. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
• TABLE 172. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
• TABLE 173. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 174. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
• TABLE 175. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
• TABLE 176. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
• TABLE 177. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
• TABLE 178. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
• TABLE 179. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
• TABLE 180. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
• TABLE 181. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
• TABLE 182. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
• TABLE 183. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 184. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 185. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
• TABLE 186. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
• TABLE 187. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 188. MEXICO GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 189. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 190. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
• TABLE 191. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
• TABLE 192. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
• TABLE 193. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 194. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
• TABLE 195. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
• TABLE 196. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
• TABLE 197. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
• TABLE 198. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
• TABLE 199. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
• TABLE 200. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
• TABLE 201. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
• TABLE 202. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
• TABLE 203. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 204. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 205. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
• TABLE 206. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
• TABLE 207. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 208. BRAZIL GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 209. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 210. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
• TABLE 211. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
• TABLE 212. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
• TABLE 213. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 214. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
• TABLE 215. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
• TABLE 216. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
• TABLE 217. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
• TABLE 218. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
• TABLE 219. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
• TABLE 220. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
• TABLE 221. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
• TABLE 222. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
• TABLE 223. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 224. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 225. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
• TABLE 226. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
• TABLE 227. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 228. ARGENTINA GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 229. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 230. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
• TABLE 231. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
• TABLE 232. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
• TABLE 233. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 234. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
• TABLE 235. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
• TABLE 236. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
• TABLE 237. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
• TABLE 238. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
• TABLE 239. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
• TABLE 240. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
• TABLE 241. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
• TABLE 242. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
• TABLE 243. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 244. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 245. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
• TABLE 246. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
• TABLE 247. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 248. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 249. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 250. EUROPE, MIDDLE EAST & AFRICA GMP CELL BANKING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 251. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 252. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
• TABLE 253. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
• TABLE 254. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
• TABLE 255. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 256. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
• TABLE 257. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
• TABLE 258. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
• TABLE 259. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
• TABLE 260. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
• TABLE 261. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
• TABLE 262. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
• TABLE 263. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
• TABLE 264. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
• TABLE 265. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 266. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 267. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
• TABLE 268. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
• TABLE 269. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 270. UNITED KINGDOM GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 271. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 272. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
• TABLE 273. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
• TABLE 274. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
• TABLE 275. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 276. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
• TABLE 277. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
• TABLE 278. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
• TABLE 279. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
• TABLE 280. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
• TABLE 281. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
• TABLE 282. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
• TABLE 283. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
• TABLE 284. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
• TABLE 285. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 286. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 287. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2024 (USD MILLION)
• TABLE 288. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2025-2030 (USD MILLION)
• TABLE 289. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 290. GERMANY GMP CELL BANKING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 291. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 292. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
• TABLE 293. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2018-2024 (USD MILLION)
• TABLE 294. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY TESTING & QUALITY CONTROL, 2025-2030 (USD MILLION)
• TABLE 295. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
• TABLE 296. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY CELL TYPE, 2025-2030 (USD MILLION)
• TABLE 297. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2018-2024 (USD MILLION)
• TABLE 298. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY MAMMALIAN CELLS, 2025-2030 (USD MILLION)
• TABLE 299. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2018-2024 (USD MILLION)
• TABLE 300. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY MICROBIAL CELLS, 2025-2030 (USD MILLION)
• TABLE 301. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2018-2024 (USD MILLION)
• TABLE 302. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY STEM CELLS, 2025-2030 (USD MILLION)
• TABLE 303. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2018-2024 (USD MILLION)
• TABLE 304. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY CELL BANK TYPE, 2025-2030 (USD MILLION)
• TABLE 305. FRANCE GMP CELL BANKING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 306. FRANCE GMP CELL BANK